Fernández-Novoa L - Search Results

1

DNA Methylation in Neurodegenerative and Cerebrovascular Disorders.

Martínez-Iglesias O, Carrera I, Carril JC, Fernández-Novoa L, Cacabelos N, Cacabelos R. Martínez-Iglesias O, et al. Among authors: fernandez novoa l. Int J Mol Sci. 2020 Mar 23;21(6):2220. doi: 10.3390/ijms21062220. Int J Mol Sci. 2020. PMID: 32210102 Free PMC article.

2

Cerebrovascular risk factors in Alzheimer's disease: brain hemodynamics and pharmacogenomic implications.

Cacabelos R, Fernández-Novoa L, Lombardi V, Corzo L, Pichel V, Kubota Y. Cacabelos R, et al. Neurol Res. 2003 Sep;25(6):567-80. doi: 10.1179/016164103101202002. Neurol Res. 2003. PMID: 14503010 Review.

3

Genomics and pharmacogenomics of brain disorders.

Cacabelos R, Martinez-Bouza R, Carril JC, Fernandez-Novoa L, Lombardi V, Carrera I, Corzo L, McKay A. Cacabelos R, et al. Curr Pharm Biotechnol. 2012 Apr;13(5):674-725. doi: 10.2174/138920112799857576. Curr Pharm Biotechnol. 2012. PMID: 22122480 Review.

4

Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.

Cacabelos R, Martínez R, Fernández-Novoa L, Carril JC, Lombardi V, Carrera I, Corzo L, Tellado I, Leszek J, McKay A, Takeda M. Cacabelos R, et al. Int J Alzheimers Dis. 2012;2012:518901. doi: 10.1155/2012/518901. Epub 2012 Mar 14. Int J Alzheimers Dis. 2012. PMID: 22482072 Free PMC article.

5

Immunocytochemical characterization of Alzheimer disease hallmarks in APP/PS1 transgenic mice treated with a new anti-amyloid-β vaccine.

Carrera I, Etcheverría I, Li Y, Fernández-Novoa L, Lombardi V, Vigo C, Palacios HH, Benberin VV, Cacabelos R, Aliev G. Carrera I, et al. Biomed Res Int. 2013;2013:709145. doi: 10.1155/2013/709145. Epub 2013 Sep 9. Biomed Res Int. 2013. PMID: 24089686 Free PMC article.

6

A comparative evaluation of a novel vaccine in APP/PS1 mouse models of Alzheimer's disease.

Carrera I, Etcheverría I, Fernández-Novoa L, Lombardi VR, Lakshmana MK, Cacabelos R, Vigo C. Carrera I, et al. Biomed Res Int. 2015;2015:807146. doi: 10.1155/2015/807146. Epub 2015 Feb 11. Biomed Res Int. 2015. PMID: 25759822 Free PMC article.

7

Histamine and Immune Biomarkers in CNS Disorders.

Cacabelos R, Torrellas C, Fernández-Novoa L, López-Muñoz F. Cacabelos R, et al. Among authors: fernandez novoa l. Mediators Inflamm. 2016;2016:1924603. doi: 10.1155/2016/1924603. Epub 2016 Apr 13. Mediators Inflamm. 2016. PMID: 27190492 Free PMC article. Review.

8

Neuroprotective Effect of Atremorine in an Experimental Model of Parkinson's Disease.

Carrera I, Fernandez-Novoa L, Sampedro C, Cacabelos R. Carrera I, et al. Among authors: fernandez novoa l. Curr Pharm Des. 2017;23(18):2673-2684. doi: 10.2174/1381612823666170210143530. Curr Pharm Des. 2017. PMID: 28190394

9

Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinson's Disease.

Cacabelos R, Carrera I, Alejo R, Fernández-Novoa L, Cacabelos P, Corzo L, Rodríguez S, Alcaraz M, Tellado I, Cacabelos N, Pego R, Carril JC. Cacabelos R, et al. Among authors: fernandez novoa l. Planta Med. 2019 Nov;85(17):1351-1362. doi: 10.1055/a-1013-7686. Epub 2019 Sep 26. Planta Med. 2019. PMID: 31559607 Clinical Trial.

10

Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer's Disease.

Cacabelos R, Carril JC, Corzo L, Fernández-Novoa L, Pego R, Cacabelos N, Cacabelos P, Alcaraz M, Tellado I, Naidoo V. Cacabelos R, et al. Among authors: fernandez novoa l. Pharmaceuticals (Basel). 2021 Apr 15;14(4):366. doi: 10.3390/ph14040366. Pharmaceuticals (Basel). 2021. PMID: 33920985 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page